- Home
- ETWO vs LENZ Comparison
ETWO vs LENZ Comparison
Compare ETWO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETWO
- LENZ
- Stock Information
- Founded
- ETWO 2000
- LENZ 2019
- Country
- ETWO United States
- LENZ United States
- Employees
- ETWO N/A
- LENZ N/A
- Industry
- ETWO EDP Services
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- ETWO Technology
- LENZ Health Care
- Exchange
- ETWO Nasdaq
- LENZ Nasdaq
- Market Cap
- ETWO 788.8M
- LENZ 679.4M
- IPO Year
- ETWO N/A
- LENZ 2021
- Fundamental
- Price
- ETWO $2.35
- LENZ $23.49
- Analyst Decision
- ETWO Sell
- LENZ Strong Buy
- Analyst Count
- ETWO 4
- LENZ 6
- Target Price
- ETWO $3.28
- LENZ $35.40
- AVG Volume (30 Days)
- ETWO 1.3M
- LENZ 98.3K
- Earning Date
- ETWO 01-10-2025
- LENZ 11-06-2024
- Dividend Yield
- ETWO N/A
- LENZ 60.66%
- EPS Growth
- ETWO N/A
- LENZ N/A
- EPS
- ETWO N/A
- LENZ N/A
- Revenue
- ETWO $613,459,000.00
- LENZ N/A
- Revenue This Year
- ETWO N/A
- LENZ N/A
- Revenue Next Year
- ETWO $1.84
- LENZ N/A
- P/E Ratio
- ETWO N/A
- LENZ N/A
- Revenue Growth
- ETWO N/A
- LENZ N/A
- 52 Week Low
- ETWO $2.34
- LENZ $2.57
- 52 Week High
- ETWO $5.08
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- ETWO 30.26
- LENZ 35.48
- Support Level
- ETWO $2.74
- LENZ $24.01
- Resistance Level
- ETWO $2.84
- LENZ $25.90
- Average True Range (ATR)
- ETWO 0.11
- LENZ 1.08
- MACD
- ETWO -0.04
- LENZ 0.02
- Stochastic Oscillator
- ETWO 1.67
- LENZ 9.02
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.